Medicine Recommendations

Black

Black

Black

Black

Black

Black

Black

Pending

Black

Electronic-cigarettes (e-cigarettes)

Date Posted: 01 - Sep - 2016

BNF chapter: Central nervous system

Expand/Collapse

To relieve and/or prevent withdrawal symptoms and reduce the cravings associated with tobacco dependence

Please note: eVoke and Voke are different products. For Voke see separate entry

Red

Red

Red

Red

Red

Red

Red

Red

Red

Eltrombopag

Date Posted: 01 - Nov - 2018

BNF chapter: Blood and Nutrition

Expand/Collapse

Eltrombopag for treating chronic immune (idiopathic) Thrombocytopenic Purpura (NICE TA293)

MHRA Drug Safety Update - Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results

Black

Black

Black

Black

Black

Black

Black

Black

Black

Eltrombopag

Date Posted: 01 - Feb - 2016

BNF chapter: Blood and Nutrition

Expand/Collapse

Treating severe aplastic anaemia refractory to immunosuppressive therapy (terminated appraisal NICE TA382)

MHRA Drug Safety Update - Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results

Red

Pending

Red

Red

Pending

Red

Red

Red

Pending

Eltrombopag

Date Posted: 01 - May - 2014

BNF chapter: Blood and Nutrition

Expand/Collapse

Treatment of Thrombocytopenia in adults with Hepatitis C

MHRA Drug Safety Update - Eltrombopag (Revolade): reports of interference with bilirubin and creatinine test results

Red

Red

Red

Red

Red

Red

Red

Red

Red

Eluxadoline

Date Posted: 01 - Apr - 2018

BNF chapter: Gastro-intestinal system

Expand/Collapse

Treating irritable bowel syndrome with diarrhoea (NICE TA471)

MHRA Drug Safety Update - Eluxadoline (Truberzi▼): risk of pancreatitis; do not use in patients who have undergone cholecystectomy or in those with biliary disorders

Green

Green

Green

Green

Green

Green

Green

Green

Green

Empagliflozin

Date Posted: 01 - Apr - 2015

BNF chapter: Endocrine system

Expand/Collapse

In combination therapy for treating type 2 diabetes (NICE TA336)

MHRA Drug Safety Update - SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin): risk of diabetic ketoacidosis

Green

Green

Green

Green

Green

Green

Green

Green

Green

Empagliflozin

Date Posted: 01 - Jun - 2016

BNF chapter: Endocrine system

Expand/Collapse

Monotherapy for treating type 2 diabetes (NICE TA390)

MHRA Drug Safety Update - SGLT2 inhibitors (canagliflozin, dapagliflozin, empagliflozin): risk of diabetic ketoacidosis

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Empagliflozin

Date Posted: 19 - Apr - 2022

BNF chapter: Cardiovascular system

Expand/Collapse

Treating chronic heart failure with reduced ejection fraction (NICE TA773)

NICE TA773 - Empagliflozin for treating chronic heart failure with reduced ejection fraction

Green (R)(Restricted)

Green (R)(Restricted)

Green (R)(Restricted)

Green (R)(Restricted)

Green (R)(Restricted)

Green (R)(Restricted)

Green (R)(Restricted)

Green (R)(Restricted)

Green (R)(Restricted)

Enerzair Breezhaler (glycopyrronium/mometasone/indacterol)

Date Posted: 12 - Sep - 2022

BNF chapter: Respiratory system

Expand/Collapse

Asthma

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Amber 0

Pending

Entacapone

Date Posted: 01 - Oct - 2014

BNF chapter: Central nervous system

Expand/Collapse

Adjunct to co-beneldopa or co-careldopa in Parkinson's disease

Amber 0

Pending

Amber 0

Amber 0

Pending

Amber 0

Amber 0

Amber 0

Amber 0

Eplerenone

Date Posted: 01 - Feb - 2016

BNF chapter: Cardiovascular system

Expand/Collapse

Heart Failure (as per the product license)

Red

Red

Red

Red

Red

Red

Red

Red

Red

Erenumab

Date Posted: 08 - Apr - 2021

BNF chapter: Central nervous system

Expand/Collapse

For preventing migraine (NICE TA682)

Green (R)(Restricted)

Green

Green (R)(Restricted)

Green (R)(Restricted)

Green

Green (R)(Restricted)

Green (R)(Restricted)

Green (R)(Restricted)

Pending

Ertugliflozin

Date Posted: 01 - Apr - 2019

BNF chapter: Endocrine system

Expand/Collapse

Ertugliflozin as monotherapy or with metformin for treating type 2 diabetes (TA572)

Green (R)(Restricted)

Green

Green (R)(Restricted)

Green (R)(Restricted)

Green

Green (R)(Restricted)

Green (R)(Restricted)

Green (R)(Restricted)

Green (R)(Restricted)

Ertugliflozin with metformin and a dipeptidyl peptidase-4 inhibitor

Date Posted: 01 - Jul - 2019

BNF chapter: Endocrine system

Expand/Collapse

Treating type 2 diabetes (NICE TA583)

Green

Green

Green

Green

Green

Green

Green

Green

Pending

Escitalopram

Date Posted: 01 - May - 2013

BNF chapter: Central nervous system

Expand/Collapse

Generalised anxiety disorder

MHRA Drug Safety Update - Citalopram and escitalopram: QT interval prolongation

FOR FYLDE & WYRE CCG ONLY - Consultant initiated, only after Sertraline tried.

Green (R)(Restricted)

Pending

Green (R)(Restricted)

Green (R)(Restricted)

Pending

Green (R)(Restricted)

Green (R)(Restricted)

Pending

Pending

Escitalopram

Date Posted: 01 - Jul - 2015

BNF chapter: Central nervous system

Expand/Collapse

Major Depressive illness

MHRA Drug Safety Update - Citalopram and escitalopram: QT interval prolongation

Grey

Pending

Pending

Pending

Pending

Pending

Pending

Pending

Pending

Esketamine nasal spray

Date Posted: 16 - Sep - 2020

BNF chapter: Central nervous system

Expand/Collapse

in combination with a SSRI or SNRI, is indicated for adults with treatment-resistant Major Depressive Disorder, who have not responded to at least two different treatments with antidepressants in the current moderate to severe depressive episode.

Amber 0

Pending

Amber 0

Pending

Pending

Amber 0

Pending

Amber 0

Pending

Eslicarbazepine

Date Posted: 01 - Dec - 2014

BNF chapter: Central nervous system

Expand/Collapse

Adjunctive therapy in patients with partial-onset seizures with or without secondary generalisation

MHRA Drug Safety Update - Carbamazepine, oxcarbazepine and eslicarbazepine: potential risk of serious skin reactions

MHRA Drug Safety Update - Antiepileptic drugs: updated advice on switching between different manufacturers’ products

Grey

Pending

Pending

Pending

Pending

Pending

Pending

Pending

Pending

Estradiol / micronised progesterone

Date Posted: 19 - Oct - 2022

BNF chapter: Endocrine system

Expand/Collapse

Continuous combined hormone replacement therapy (HRT) for estrogen deficiency symptoms in postmenopausal women with intact uterus and with at least 12 months since last menses

Red

Red

Red

Red

Red

Red

Red

Red

Red

Etanercept

Date Posted: 01 - Feb - 2016

BNF chapter: Musculoskeletal system

Expand/Collapse

Rheumatoid arthritis (LSCMMG pathway)